Insider Transactions in Q3 2025 at Immuneering Corp (IMRX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2025
|
Peter Feinberg Director |
BUY
Open market or private purchase
|
Direct |
7,500
+4.78%
|
$52,500
$7.03 P/Share
|
|
Sep 29
2025
|
Peter Feinberg Director |
BUY
Open market or private purchase
|
Direct |
5,000
+3.41%
|
$35,000
$7.18 P/Share
|
|
Sep 15
2025
|
Leah R Neufeld CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,815
+34.39%
|
$11,815
$1.43 P/Share
|
|
Sep 15
2025
|
Mallory Morales Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,497
+34.74%
|
$14,497
$1.43 P/Share
|
|
Sep 15
2025
|
Brett Matthew Hall CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,880
+3.82%
|
$14,880
$1.43 P/Share
|
|
Jul 02
2025
|
Diana Hausman Director |
BUY
Open market or private purchase
|
Indirect |
3,000
+50.0%
|
$9,000
$3.62 P/Share
|
|
Jul 02
2025
|
Diana Hausman Director |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
$7,500
$3.6 P/Share
|
|
Jul 02
2025
|
Leah R Neufeld CHIEF PEOPLE OFFICER |
BUY
Open market or private purchase
|
Direct |
700
+6.12%
|
$2,100
$3.57 P/Share
|
|
Jul 02
2025
|
Benjamin J. Zeskind PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
7,015
+0.3%
|
$21,045
$3.53 P/Share
|
|
Jul 01
2025
|
Benjamin J. Zeskind PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
2,985
+0.13%
|
$8,955
$3.38 P/Share
|